Medication info
Congbruc Tablet 1.25 mg (Bisoprolol Fumarate)

Congbruc Tablet 1.25 mg (Bisoprolol Fumarate)

Prescription medicationTabletOral
Ingredient · strength
Bisoprolol Fumarate›1.25mg / 1 tablet
Manufacturer / importer
Erison Pharmaceutical Co., Ltd.
Appearance
Light yellow round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201405617 · Approved 2014.11.28 · Insurance code 620500120

Summary

Main use
Treatment of stable chronic heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take in the morning on an empty stomach or with breakfast, with a drink, without chewing. Stable chronic heart failure Adults: Administer orally once daily, increasing the dose of bisoprolol fumarate as follows. Treatment with this drug should be initiated when the patient is stable and has no acute symptoms of heart failure. Dose escalation The initial dose of this drug is 1.25mg once daily. Monitor tolerability and gradually increase the dose in the following order, allowing an interval of at least 2 weeks at each step: 2.5mg, 3.75mg, 5mg, 7.5mg, and 10mg. The maintenance dose is 10mg once daily. The recommended maximum daily dose is 10mg once daily. During dose escalation, closely monitor the patient's condition, including blood pressure and heart rate, and whether symptoms of heart failure worsen. Adjustment of treatment dose If the maximum recommended dose is not well tolerated, consider gradually reducing the dose. If transient worsening of heart failure symptoms, hypotension, or bradycardia occurs, adjustment of the doses of concomitant medications is recommended. If necessary, temporary dose reduction or discontinuation of this drug may be required. Once heart failure symptoms have stabilized, consider restarting this drug or increasing the dose. Because abrupt discontinuation of this drug may cause acute worsening of heart failure symptoms, gradual dose reduction is recommended. Treatment of stable chronic heart failure with this drug is generally long-term. Patients with hepatic or renal impairment Pharmacokinetic information has not been established in patients with chronic heart failure and these conditions; therefore, use particular caution when increasing the dose in these patients. Elderly patients No dose adjustment is necessary.
Child dose
Pediatrics: Use is not recommended because there is no experience with this drug in children.

Ingredients

Manufacturer
Erison Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of stable chronic heart failure with reduced left ventricular systolic function

  • Reduced left ventricular systolic function
  • stable chronic heart failure
View approved original text

This medication is used to treat patients with stable chronic heart failure with reduced systolic function of the left ventricle. It is often used in combination with ACE inhibitors and diuretics, and may be administered with cardiac glycosides if necessary. This helps to improve heart function, relieve symptoms, and enhance quality of life.

How to take

Adult dose

Take in the morning on an empty stomach or with breakfast, with a drink, without chewing. Stable chronic heart failure Adults: Administer orally once daily, increasing the dose of bisoprolol fumarate as follows. Treatment with this drug should be initiated when the patient is stable and has no acute symptoms of heart failure. Dose escalation The initial dose of this drug is 1.25mg once daily. Monitor tolerability and gradually increase the dose in the following order, allowing an interval of at least 2 weeks at each step: 2.5mg, 3.75mg, 5mg, 7.5mg, and 10mg. The maintenance dose is 10mg once daily. The recommended maximum daily dose is 10mg once daily. During dose escalation, closely monitor the patient's condition, including blood pressure and heart rate, and whether symptoms of heart failure worsen. Adjustment of treatment dose If the maximum recommended dose is not well tolerated, consider gradually reducing the dose. If transient worsening of heart failure symptoms, hypotension, or bradycardia occurs, adjustment of the doses of concomitant medications is recommended. If necessary, temporary dose reduction or discontinuation of this drug may be required. Once heart failure symptoms have stabilized, consider restarting this drug or increasing the dose. Because abrupt discontinuation of this drug may cause acute worsening of heart failure symptoms, gradual dose reduction is recommended. Treatment of stable chronic heart failure with this drug is generally long-term. Patients with hepatic or renal impairment Pharmacokinetic information has not been established in patients with chronic heart failure and these conditions; therefore, use particular caution when increasing the dose in these patients. Elderly patients No dose adjustment is necessary.

Child dose

Pediatrics: Use is not recommended because there is no experience with this drug in children.

Precautions

This medication affects the heart and blood pressure, and may not be safe for patients with specific diseases or conditions. Patients with bronchial asthma or chronic obstructive pulmonary disease should use a bronchodilator alongside this medication, and for asthma patients, airway resistance may increase requiring adjustment of bronchodilator dosage. Allergic reactions may occur, so adrenaline treatment may not always be effective. Patients with psoriasis or a history of psoriasis need to carefully consider the risks and benefits of using this medication. Patients with certain hormone-related tumors should receive other medications first before this one, and symptoms of hyperthyroidism may be masked by this drug. Regular monitoring is necessary when initiating this medication, and abrupt discontinuation can worsen heart conditions, so it must be tapered off gradually under a doctor's guidance. Patients with diabetic ketoacidosis, cardiac conduction disorders, severe hypotension, or severe asthma should not use this medication. Patients with bronchial asthma, respiratory diseases, heart failure, and poor liver or kidney function should use this medication cautiously, as hypoglycemic symptoms may be masked. Side effects such as bradycardia, hypotension, dizziness, fatigue, and digestive disturbances may occur while on this medication. Long-term use requires regular monitoring of heart function and liver and kidney status, and abrupt discontinuation should be avoided. This medication may interact with other drugs, so all medications being taken should be disclosed to the physician, and should not be used in combination with certain drugs or should be used with caution. Pregnant women or those who may become pregnant should not use this medication, as it can harm the fetus and newborn, and breastfeeding mothers should avoid it or stop breastfeeding. Safety in pediatric patients has not been established, so it is not recommended for use in children. Elderly patients should start at a low dose and observe their condition carefully before using this medication. This medication may affect driving or machine operation abilities, so caution is advised, especially during the initial treatment phase or when changing medications. In case of overdose, bradycardia, hypotension, and bronchospasm may occur, requiring immediate medical attention.

Side effects

  • Bradycardia
  • worsening of heart failure
  • coldness or paralysis of the limbs
  • hypotension
  • dizziness
  • headache
  • nausea
  • vomiting
  • diarrhea
  • constipation
Show 25 more
  • weakness
  • fatigue
  • atrioventricular conduction disorder
  • orthostatic hypotension
  • sleep disturbances
  • depression
  • bronchospasm
  • muscle atrophy
  • convulsions
  • nightmares
  • hallucinations
  • decreased tear production
  • hearing impairment
  • allergic rhinitis
  • hypersensitivity reactions
  • itching
  • erythema
  • rash
  • hepatitis
  • sexual dysfunction
  • conjunctivitis
  • worsening of psoriasis
  • psoriatic rash
  • hair loss
  • syncope

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is advisable to keep it at room temperature between 1°C and 30°C. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Light yellow round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.